Point72 Europe London LLP Invests $13.11 Million in CME Group Inc. $CME

Key Points

• Point72 Europe London LLP has acquired a new stake of approximately $13.11 million in CME Group Inc., purchasing 49,400 shares during the first quarter.
recent quarter earnings for CME Group showed a EPS of $2.96, exceeding analyst estimates, with revenue totaling $1.69 billion and a year-over-year increase of 10.4%.
• The company announced a quarterly dividend of $1.25 per share, with an ex-dividend date of September 9th and a 1.9% yield.

Point72 Europe London LLP acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 49,400 shares of the financial services provider's stock, valued at approximately $13,105,000.

A number of other large investors have also recently made changes to their positions in the business. ICW Investment Advisors LLC lifted its stake in shares of CME Group by 7.1% in the first quarter. ICW Investment Advisors LLC now owns 1,227 shares of the financial services provider's stock valued at $325,000 after buying an additional 81 shares in the last quarter. Alamea Verwaltungs GmbH purchased a new stake in shares of CME Group in the first quarter valued at about $873,000. MAI Capital Management raised its holdings in shares of CME Group by 1.2% in the first quarter. MAI Capital Management now owns 52,306 shares of the financial services provider's stock valued at $13,876,000 after purchasing an additional 601 shares during the last quarter. Quarry LP purchased a new stake in shares of CME Group in the first quarter valued at about $274,000. Finally, Saudi Central Bank purchased a new stake in shares of CME Group in the first quarter valued at about $38,000. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

CME Group stock traded up $3.95 during mid-day trading on Wednesday, hitting $269.35. 2,136,475 shares of the company traded hands, compared to its average volume of 1,773,067. CME Group Inc. has a one year low of $212.38 and a one year high of $290.79. The stock has a market cap of $97.07 billion, a price-to-earnings ratio of 26.07, a price-to-earnings-growth ratio of 4.82 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a fifty day moving average price of $275.39 and a 200-day moving average price of $269.61.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business posted $2.56 earnings per share. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio is 48.40%.

Insider Activity

In related news, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently commented on CME shares. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Citigroup raised their price objective on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Barclays set a $298.00 price objective on shares of CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Finally, Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $261.93.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.